Massengill Living Trust plans 2,000-share SNDK (NASDAQ: SNDK) sale
Rhea-AI Filing Summary
Massengill Living Trust has filed a notice to sell 2,000 shares of the issuer’s common stock, with an aggregate market value of $984,571.00, through Morgan Stanley Smith Barney LLC Executive Financial Services on or about 01/21/2026 on the NASDAQ. The issuer has 146,553,179 common shares outstanding.
The 2,000 shares to be sold were acquired as restricted stock that vested under a registered plan on 11/03/2016 (664 shares), 11/07/2019 (714 shares), and 11/15/2021 (622 shares), all as compensation for services rendered.
During the past three months, Massengill Living Trust has already sold additional common shares of the issuer, including 2,340 shares on 11/26/2025 for $508,394.95, 1,500 shares on 11/25/2025 for $335,625.00, 1,000 shares on 11/24/2025 for $225,089.00, 1,000 shares on 01/15/2026 for $421,459.40, 2,000 shares on 01/07/2026 for $693,838.60, and 2,816 shares on 01/06/2026 for $953,009.02.
Positive
- None.
Negative
- None.
FAQ
What securities are being sold in the Form 144 for SNDK?
The notice covers the proposed sale of 2,000 shares of the issuer’s common stock, with an aggregate market value of $984,571.00, to be traded on the NASDAQ.
Who is the selling security holder in this SNDK Form 144 filing?
The selling holder is Massengill Living Trust, which is identified as the seller of the issuer’s common stock in both the proposed transaction and the sales made during the past three months.